✦ LIBER ✦

Multiplicity issues in clinical trials

✍ Scribed by Norbert Benda; Ralf Bender

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 66 KB
Volume: 53
Category: Article
ISSN: 0323-3847
DOI: 10.1002/bimj.201100177

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Points to Consider on Multiplicity in Cl

Points to Consider on Multiplicity in Clinical Trials

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

Reimbursement issues in cancer clinical

Reimbursement issues in cancer clinical trials

✍ Robert J. McKenna 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 2 views

Evaluating multiple treatment courses in

Evaluating multiple treatment courses in clinical trials

✍ Peter F. Thall; Randall E. Millikan; Hsi-Guang Sung 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 1 views

In oncology, a patient's treatment often involves multiple courses of chemotherapy. The most common medical practice in choosing treatments for successive courses is to repeat a treatment that is successful in a given course and otherwise switch to a different treatment. Patient outcome thus consist

Challenges to multiple testing in clinic

Challenges to multiple testing in clinical trials

✍ H. M. James Hung; Sue-Jane Wang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Outcome measures for clinical trials in

Outcome measures for clinical trials in multiple sclerosis

✍ Hillel S. Panitch 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

Detecting Potential Safety Issues in Cli

Detecting Potential Safety Issues in Clinical Trials by Bayesian Screening

✍ A. Lawrence Gould 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB